Clinical Trial Update: Azithromycin Combination Therapy for Malaria [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by NIAID evaluating azithromycin in combination therapy for Plasmodium falciparum malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED